Atea Pharmaceuticals (AVIR) Cash from Investing Activities (2020 - 2026)
Atea Pharmaceuticals (AVIR) reported Cash from Investing Activities of $34.32 million for Q2 2026, up 124.4% from $15.29 million a year earlier and up 15.4% from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Atea Pharmaceuticals' Cash from Investing Activities came in at $151.95 million; for FY2025, it was $188.79 million, up 236.5% from FY2024.
- By year, Cash from Investing Activities came in at $56.11 million in FY2024 (+39.2%), $40.3 million in FY2023, -$455.41 million in FY2022 and -$4,000 in FY2021.
- Five-year quarterly Cash from Investing Activities spans a low of -$486.98 million in Q3 2022 and a high of $124.69 million in Q2 2024.
- Year over year, Cash from Investing Activities gained in two of the last four quarters, with growth averaging 5.5%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $29.74 million (Q1 2026), $46.59 million (Q4 2025) and $41.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Atea Pharmaceuticals | 411.45 Mn | 411.45 Mn | - | 34.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.32 Mn |
| Mar 31, 2026 | 29.74 Mn |
| Dec 31, 2025 | 46.59 Mn |
| Sep 30, 2025 | 41.30 Mn |
| Jun 30, 2025 | 15.29 Mn |
| Mar 31, 2025 | 85.61 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -122.01 Mn |
| Jun 30, 2024 | 124.69 Mn |
| Mar 31, 2024 | 56.80 Mn |
| Dec 31, 2023 | 27.77 Mn |
| Sep 30, 2023 | -58.51 Mn |
| Jun 30, 2023 | 46.57 Mn |
| Mar 31, 2023 | 24.48 Mn |
| Dec 31, 2022 | 33.49 Mn |
| Sep 30, 2022 | -486.98 Mn |
| Jun 30, 2022 | -1.88 Mn |
| Mar 31, 2022 | -44,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Sep 30, 2020 | -15,000.00 |
API Access
Atea Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();